Authors:
Knauber, J
Kischka, U
Roth, M
Schmidt, WJ
Hennerici, M
Fassbender, K
Citation: J. Knauber et al., Modulation of striatal acetylcholine concentrations by NMDA and the competitive NMDA receptor-antagonist AP-5: an in vivo microdialysis study, J NEURAL TR, 106(1), 1999, pp. 35-45
Authors:
Fassbender, K
Eschenfelder, C
Hennerici, M
Citation: K. Fassbender et al., Fas (APO-1/CD95) in inflammatory CNS diseases: intrathecal release in bacterial meningitis, J NEUROIMM, 93(1-2), 1999, pp. 122-125
Citation: S. Meairs et M. Hennerici, Four-dimensional ultrasonographic characterization of plaque surface motion in patients with symptomatic and asymptomatic carotid artery stenosis, STROKE, 30(9), 1999, pp. 1807-1813
Citation: M. Hennerici et al., Monitoring the effectiveness of anticoagulative therapy in left atrial spontaneous echo contrast by cerebral microemboli detection - Response, STROKE, 30(9), 1999, pp. 1977-1978
Authors:
Fassbender, K
Bertsch, T
Mielke, O
Muhlhauser, F
Hennerici, M
Citation: K. Fassbender et al., Adhesion molecules in cerebrovascular diseases - Evidence for an inflammatory endothelial activation in cerebral large- and small-vessel disease, STROKE, 30(8), 1999, pp. 1647-1650
Authors:
Fassbender, K
Dempfle, CE
Mielke, O
Schwartz, A
Daffertshofer, M
Eschenfelder, C
Dollman, M
Hennerici, M
Citation: K. Fassbender et al., Changes in coagulation and fibrinolysis markers in acute ischemic stroke treated with recombinant tissue plasminogen activator, STROKE, 30(10), 1999, pp. 2101-2104
Authors:
Fassbender, K
Mielke, O
Bertsch, T
Muehlhauser, F
Hennerici, M
Kurimoto, M
Rossol, S
Citation: K. Fassbender et al., Interferon-gamma-inducing factor (IL-18) and interferon-gamma in inflammatory CNS diseases, NEUROLOGY, 53(5), 1999, pp. 1104-1106
Authors:
Fassbender, K
Kaptur, S
Becker, P
Groschel, J
Schmidt, R
Hennerici, M
Citation: K. Fassbender et al., Inverse association between endogenous glucocorticoid secretion and L-selectin (CD62L) expression in trauma patients, LIFE SCI, 65(23), 1999, pp. 2471-2480
Authors:
Samman, I
Schulz-Schaeffer, WJ
Wohrle, JC
Sommer, A
Kretzschmar, HA
Hennerici, M
Citation: I. Samman et al., Clinical range and MRI in Creutzfeldt-Jakob disease with heterozygosity atcodon 129 and prion protein type 2, J NE NE PSY, 67(5), 1999, pp. 678-681
Authors:
Eckert, A
Cotman, CW
Zerfass, R
Hennerici, M
Muller, WE
Citation: A. Eckert et al., Lymphocytes as cell model to study apoptosis in Alzheimer's disease: vulnerability to programmed cell death appears to be altered, J NEURAL TR, 1998, pp. 259-267